Parry-Romberg syndrome is a rare disorder characterized by slowly progressive deterioration of the skin and soft tissues of half of the face. The syndrome presents with characteristic skeletal, dental, and soft tissue changes in the affected half of the face, with or without neurological signs and symptoms.
NIH Funded Articles
- Predictors of Obstructive Sleep Apnea Risk among Blacks with Metabolic Syndrome
- Objectively Coding Intervention Fidelity During A Phone-Based Obesity Prevention Study
- Molecular Mechanism Linking BRCA1 Dysfunction to High Grade Serous Epithelial Ovarian Cancers with Peritoneal Permeability and Ascites
- Endothelial Cells May Have Tissue-Specific Origins
- Wake-up Strokes Are Similar to Known-Onset Morning Strokes in Severity and Outcome
- Acculturation and Subclinical Atherosclerosis among U.S. South Asians: Findings from the MASALA study
Annex PublishersAnnex publishers is an Open Access publication model which allows the publication of articles to the world through this community. We provide you the asset of interaction with the most researchers from the scientific community. Anyone can freely access the articles printed under Annex publishers.
Open access provides an unlimited access to journals and publications, with a perfect platform for thousands of researchers to form jointly for the development of science. Open Access assists in accelerating the scientific discovery, encourage innovation, enhance education and refresh the economy to build up the knowledge of the general public.
Extramedullary Hematopoiesis in a Non-Transfused Elderly Patient Diagnosed with Beta Thalassemia Minor
Extramedullary hematopoiesis (EMH) is a compensatory reaction caused by the presence of hematopoietic precursors outside the bone marrow, ineffective erythropoiesis and patients with chronic hemolytic anemia. The most frequent cause of EMH is thalassemia intermedia, that produces an increase in demand of the hematopoietic system caused by anemia and is not reduced by transfusion therapy.
This review intends to provide brief data about the psychological consequences of induced unsafe abortion. The data were collected from different articles, journals, guidelines and related published materials.
The de-extinction of the dinosaur is a dubious possibility but its consideration brings forth some issues that are at least worthy of scientific discussion. In this review, we discuss two distinct issues that have implications for a de-extinct species such as a dinosaur: the ability, or lack thereof, to safely sedate a rare and potentially fractious animal capable of harming the veterinary staff tasked with its care; and, disease risks associated with a species that has been extinct for millions of years. To identify potential sedatives, comparative pharmacology will be needed to uncover the links between receptor pharmacology and the desired clinical outcomes of activating established alpha-2 adrenergic, opioid, and benzodiazepine receptors. Specific to disease control, it will be necessary to understand the unique susceptibility of the new species to current diseases as well as predicting their reservoir capacity for potential human and veterinary pandemic diseases. While the topics presented herein are not exhaustive, this review highlights some of the foremost research that should be conducted in order to serve the unique veterinary needs of a de-extinct species using the dinosaur as a paradigm. Addressing these issues should be considered if an intact dinosaur genome becomes available, regardless of the feasibility of dinosaur resurrection.